Coginko Fruits Rouges
Food supplement declared in France, declaration No 2023-8-1661, decision dated 31 August 2023
Coginko Fruits Rouges (Coginko) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 3 rules of use apply to its ingredients (limits and warnings).
- Brand
- Coginko
- Food business operator placing the product on the market
- COGINKO
- Status
- Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
- Form
- Poudre
- Daily dose
- 2,8g
- Directions for use
- produit sous forme de poudre, à reconstituer dans de l’eau
- Intended populations
- Homme, Femme
- Not recommended for (according to the manufacturer)
- Adolescents (moins de 18 ans), Femmes allaitantes, Enfants (moins de 12 ans), Enfants en bas âge (1 à 3 ans), Femmes enceintes, Nourrissons (moins de 1 an), Sous anticoagulants, Sous antidépresseurs, Sous antidiabétiques, Sous traitement antihypertenseur, Sous traitement médicamenteux, Sous traitement pour la thyroïde, Enfants (de moins de 6 ans), Enfants (de moins de 10 ans)
- Objectives stated by the manufacturer (these are not authorised claims)
- Mémoire, Système nerveux, Concentration
- Flavourings
- Fruits Rouges
Declaration 326661, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
Source: Regulation (EC) No 1925/2006, latest consolidated version, annexe III, partie B (règlement (UE) 2022/2340).
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Camellia sinensis (L.) Kuntze | Feuille | Extrait sec hydroalcoolique | 750 mg |
| Bacopa monnieri (L.) Wettst. | Feuille | Extrait sec hydroalcoolique | 300 mg |
| Sedum roseum (L.) Scop. | Racine | Extrait sec hydroalcoolique | 260 mg |
| Ginkgo biloba L. | Feuille | Extrait sec hydroalcoolique | 200 mg |
| Panax ginseng C.A.Mey. | Feuille | Extrait sec hydroalcoolique | 40 mg |
Additives
E330, E120, E960
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Label warnings
À tenir hors de portée des enfants. Les complémentsalimentaires ne se substituent pas à un régime alimentaire variéet équilibré et à un mode de vie sain. Ne pas dépasser la dosejournalière recommandée. Consultez votre médecin en cas deprise simultanée d’anticoagulant. Ne doit pas être consommé àjeun. Ne doit pas être consommé si vous prenez le même jourd’autres produits contenant du thé vert. Ne doit pas êtreconsommé par les enfants de moins de 18 ans ni par lespersonnes sous traitement (notamment antidépresseurs etantidiabétiques) ainsi que chez les femmes enceintes ouallaitantes. Ne pas dépasser une consommation journalière égaleou supérieure à 800 mg d EGCG
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Sedum roseum (L.) Scop.
Read the warning, when it applies and the studies cited
RHODIOLA - RHODIOLA ROSEA
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (EMA 2024).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking antidepressant medication, hormone replacement therapy (HRT) or birth control medication (HC 2018; Iovieno et al. 2011; Olsson et al. 2009; Brown et al. 2002).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Do not use if you have bipolar disorder or bipolar spectrum disorder (Iovieno et al. 2011; Winston and Maimes 2007; Brown et al. 2002).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Stop use if you experience irritability or insomnia (Pizzorno and Murray 2006; Kelly 2001).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
- Ginkgo biloba L.
Read the warning, when it applies and the studies cited
GINKGO - GINKGO BILOBA
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Blumenthal et al. 2000; WHO 1999).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking diabetes, high blood pressure or seizure medications (Brinker 2010).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Do not use if you are having a surgery (Gardner and McGuffin 2013).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Do not use if you are taking blood thinners or other health products that affect blood coagulation (Gardner and McGuffin 2013; Brinker 2010; Bent 2005).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
- Panax ginseng C.A.Mey.
Read the warning, when it applies and the studies cited
PANAX GINSENG
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Brinker 2010; Vuksan et al. 2008; Seely et al. 2008; Sievenpiper et al. 2006; ESCOP 2003; Tetsutani et al. 2000; Sotaniemi et al. 1995; Chin 1991).
8 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking antidepressant medication, blood thinners or digoxin (Brinker 2010; Lee et al. 2008a; Dasgupta and Reyes 2005; Janetzki and Morreale 1997; Gonzalez-Seijo et al. 1995; Shader and Greenblatt 1988; Jones and Runikis 1987; Shader and Greenblatt 1985).
8 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Condition of application: Traditional Chinese Medicine.
Do not use in cases of yin deficiency with heat signs, heat excess, or in the absence of significant qi deficiency (Bensky et al. 2004).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if you experience insomnia, anxiety or headaches (Lee et al. 2008b; Vuksan et al 2008; de Andrade et al.2007; Sievenpiper et al. 2006; Coon and Ernst 2002; Ellis and Reddy 2002; Scaglione et al. 2001; Siegel 1979).
8 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Brand : Coginko
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.